Dr Ramatoulie Janha
Address: Address: MRC Keneba, MRC Unit The Gambia, PO Box 273, Banjul, The Gambia
Background: Ramatoulie obtained a BSc. (Honours) in Biochemistry from the University of Ghana Legon before joining MRC Gambia Unit. She won a scholarship from the European and Developing Countries Clinical Trials Partnership to undertake a PhD research degree project in Pharmacogenomics of an antimalarial drug (chlorproguanil/dapsone – LapdapTM) that was in a clinical trial with the current first-line antimalarial coarthemeter in MRC Farafenni Field Station, The Gambia. She was awarded a PhD degree in 2011 by the UK Open University and thereafter worked under the Molecular Diagnostics Platform of the MRC Gambia Unit, mainly managing resources and offering molecular diagnostics services to senior scientists in the unit and the sub-region. In 2013, she won an MRC Centenary award that was used to investigate the variation in Plasmodium falciparum drug resistant genes following the implementation of artemisinin-based combination therapy in The Gambia, before joining MRC ING in July 2014.
Current Research: She is a Senior Scientific Officer/Deputy Local Head of the Calcium, Vitamin D and Bone Health (CDBH) Group of MRC ING and has interests in the long-term outcome of the calcium-carbonate supplementation trials of the group and the genetic and epigenetic mechanisms underpinning some of the results. She is currently leading the follow-up of the randomised placebo-controlled calcium-carbonate supplementation trial in pregnant women 20-years later, to assess the effects of the calcium-carbonate supplement on bone health phenotypes of the rural women at a time when they have reached mid-life.